WHO ICTRP trial
A phase II, controlled, single centre, open study to evaluate the safety…
EUCTR2007-002783-10-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2007-002783-10-BE |
|---|---|
| Public title | A phase II, controlled, single centre, open study to evaluate the safety, reactogenicity and immunogenicity of a second vaccination with the low dose influenza vaccine adjuvanted with a reduced dose of AS03, compared to a second dose of Fluarix™ (GlaxoSmithKline Biologicals) administered intramuscularly in subjects 18-60 years previously vaccinated in FLU-LD-004 clinical trial. - FLU-LD-010 EXT: 004 Y1 |
| Scientific title | A phase II, controlled, single centre, open study to evaluate the safety, reactogenicity and immunogenicity of a second vaccination with the low dose influenza vaccine adjuvanted with a reduced dose of AS03, compared to a second dose of Fluarix™ (GlaxoSmithKline Biologicals) administered… |
| Primary sponsor | GlaxoSmithKline Biologicals |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Belgium |
| Conditions | Re-vaccination against influenza in male and female subjects aged 18-60 years old. |
| Interventions | Product Name: GlaxoSmihKline Biologicals low dose influenza vaccine adjuvanted with AS03 (half dose of AS03) Product Code: Flu-LD Pharmaceutical Form: Emulsion for injection INN or Proposed INN: Haemagglutinin from A/Solomon Islands/3/2006… |
| Registration date | Aug 20, 2007 |
| Target size | 300 |
| Secondary IDs | 110674 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: